Literature DB >> 32241902

Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study.

Ru Chen1, Yong Liu2, Guohui Song3, Bianyun Li4, Deli Zhao5, Zhaolai Hua6, Xinzheng Wang7, Jun Li8, Changqing Hao9, Liwei Zhang10, Shuzheng Liu11, Jialin Wang12, Jinyi Zhou13, Yongzhen Zhang14, Bo Li15, Yanyan Li5, Xiang Feng6, Lin Li8, Zhiwei Dong16, Wenqiang Wei17, Guiqi Wang18.   

Abstract

OBJECTIVES: To estimate the effectiveness of endoscopic screening programme in reducing incidence and mortality of upper gastrointestinal cancer in high risks areas of China.
DESIGN: This multicentre population-based cohort study was conducted in six areas in China from 2005 to 2015. All permanent residents aged 40 to 69 years were identified as target subjects. We refer to those who were invited for screening collectively as the invited group. Of these, we classify those who were invited and undertook endoscopic screening as the screened group and those who were invited but did not accept screening as the non-screened group. Target subjects who were not invited to the screening were assigned to the control group. The effectiveness of the endoscopic screening and screening programme were evaluated by comparing reductions in incidence and mortality from upper gastrointestinal cancer in the screened and invited group with control group.
RESULTS: Our cohort analysis included 637 500 people: 299 483 in the control group and 338 017 in the invited to screening group, 113 340 (33.53%) of whom were screened eventually. Compared with subjects in the control group, upper gastrointestinal cancer incidence and mortality decreased by 23% (relative risk (RR)=0.77, 95% CI 0.74 to 0.81) and 57% (RR=0.43, 95% CI 0.40 to 0.47) in the screened group, respectively, and by 14% (RR=0.86, 95% CI 0.84 to 0.89) and 31% (RR=0.69, 95% CI 0.66 to 0.72) in the invited group, respectively.
CONCLUSION: Among individuals aged 40 to 69 years in high risk areas of upper gastrointestinal cancer, one-time endoscopic screening programme was associated with a significant decrease in upper gastrointestinal cancer incidence and mortality. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endoscopy; gastric cancer; oesophageal cancer; screening

Year:  2020        PMID: 32241902     DOI: 10.1136/gutjnl-2019-320200

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

Review 1.  Tobacco Smoking and Gastrointestinal Cancer Risk.

Authors:  Hans Scherübl
Journal:  Visc Med       Date:  2022-03-17

2.  Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors.

Authors:  Linlin Ji; Jianping Wang; Bo Yang; Jianping Zhu; Yini Wang; Jiaqi Jiao; Kai Zhu; Min Zhang; Liqiang Zhai; Tongqing Gong; Changqing Sun; Jun Qin; Guangshun Wang
Journal:  Esophagus       Date:  2022-07-06       Impact factor: 3.671

3.  Effect of dietary consumption on the survival of esophageal squamous cell carcinoma: a prospective cohort study.

Authors:  Yue Zhao; Wenjing Zhao; Jun Li; Sihao Lin; Lin Li; Zefang Ren; Jiahai Lu; Xiangbing Xing; Xudong Liu
Journal:  Eur J Clin Nutr       Date:  2022-08-16       Impact factor: 4.884

4.  Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.

Authors:  Shuxia Qin; Xuehong Wang; Sini Li; Chongqing Tan; Xiaohui Zeng; Xia Luo; Lidan Yi; Liubao Peng; Meiyu Wu; Ye Peng; Liting Wang; Xiaomin Wan
Journal:  Pharmacoeconomics       Date:  2022-06-15       Impact factor: 4.558

5.  A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial results.

Authors:  Xiao-Yang Wang; Shu-Zheng Liu; Hui-Fang Xu; Yin Liu; Hong Wang; Rui-Hua Kang; Qiong Chen; Lu-Yao Zhang; Lan-Wei Guo; Li-Yang Zheng; Chun-Ya Liu; Yi-Xian Wang; Yi-Ping Jing; You-Lin Qiao; Bin-Bin Han; Shao-Kai Zhang
Journal:  Ann Transl Med       Date:  2022-09

6.  Asian Gastric Cardia Adenocarcinoma: A distinct and understudied cancer with etiologic similarities to both esophageal squamous cell carcinoma and noncardia gastric adenocarcinoma.

Authors:  Christian C Abnet
Journal:  J Natl Cancer Cent       Date:  2021-03-17

7.  Endoscopic resections for superficial esophageal squamous cell epithelial neoplasia: focus on histological discrepancies between biopsy and resected specimens.

Authors:  Lang Yang; Hua Jin; Xiao-Li Xie; Yang-Tian Cao; Zhen-Hua Liu; Na Li; Peng Jin; Yu-Qi He; Jian-Qiu Sheng
Journal:  BMC Gastroenterol       Date:  2021-03-09       Impact factor: 2.847

8.  Microbial Diversity and Composition in Six Different Gastrointestinal Sites among Participants Undergoing Upper Gastrointestinal Endoscopy in Henan, China.

Authors:  Minjuan Li; Dantong Shao; Jiachen Zhou; Jianhua Gu; Junjie Qin; Xinqing Li; Changqing Hao; Wenqiang Wei
Journal:  Microbiol Spectr       Date:  2022-04-25

9.  Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China.

Authors:  Hongmei Zeng; Kexin Sun; Maomao Cao; Rongshou Zheng; Xibin Sun; Shuzheng Liu; Zhiyi Zhang; Yuqin Liu; Guizhou Guo; Guohui Song; Yigong Zhu; Xianghong Wu; Bingbing Song; Xianzhen Liao; Yanfang Chen; Mingyang Song; Edward Giovannucci; Guihua Zhuang; Wenqiang Wei; Wanqing Chen; Jie He
Journal:  BMC Gastroenterol       Date:  2020-11-24       Impact factor: 3.067

10.  Screening for gastric cancer in China: Advances, challenges and visions.

Authors:  Xiaohan Fan; Xiangxiang Qin; Yang Zhang; Zhexuan Li; Tong Zhou; Jingying Zhang; Weicheng You; Wenqing Li; Kaifeng Pan
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.